Torrent Pharmaceuticals surges despite getting observations from USFDA for Indrad plant

26 Apr 2019 Evaluate

Torrent Pharmaceuticals is currently trading at Rs. 1750.95, up by 23.05 points or 1.33% from its previous closing of Rs. 1727.90 on the BSE.

The scrip opened at Rs. 1723.25 and has touched a high and low of Rs. 1772.25 and Rs. 1723.00 respectively. So far 5738 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1964.00 on 29-Mar-2019 and a 52 week low of Rs. 1282.00 on 25-May-2018.

Last one week high and low of the scrip stood at Rs. 1823.25 and Rs. 1720.00 respectively. The current market cap of the company is Rs. 29516.77 crore.

The promoters holding in the company stood at 71.25%,while Institutions and Non-Institutions held 19.14% and 9.61% respectively.

Torrent Pharmaceuticals has received certain observations from the US Food and Drug Administration (USFDA) for Indrad Plant which are procedural in nature and the company is confident of addressing them satisfactorily. The audit at Indrad Plant of the company was carried out by USFDA in the month of April, 2019.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

2693.35 34.30 (1.29%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.